Follow-up program for patients with esophageal cancer
Standard Follow-up Program (SFP) for Esophageal Cancer Patients Treated With Radiotherapy or Chemoradiation
University Medical Center Groningen · NCT02454790
This study is trying to create a follow-up program for people with esophageal cancer to see how well treatments work and how they affect quality of life, so doctors can make better treatment choices in the future.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 10000 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | University Medical Center Groningen (other) |
| Locations | 1 site (Groningen) |
| Trial ID | NCT02454790 on ClinicalTrials.gov |
What this trial studies
This observational study aims to establish a comprehensive follow-up program for patients with esophageal cancer to collect relevant data on treatment outcomes, side effects, and patient-reported quality of life. The study will create a database linking treatment results with dose-volume data from radiotherapy, which will help in developing prediction models for tumor control and toxicity. The ultimate goal is to enhance treatment selection for patients undergoing proton therapy based on the collected data.
Who should consider this trial
Good fit: Ideal candidates for this study are patients diagnosed with esophageal cancer who are receiving a radiotherapy dose greater than 40 Gy.
Not a fit: Patients who do not meet the inclusion criteria or are not receiving the specified radiotherapy dose may not benefit from this study.
Why it matters
Potential benefit: If successful, this program could lead to improved treatment strategies and better patient outcomes for those with esophageal cancer.
How similar studies have performed: Other studies have shown success in utilizing follow-up programs and databases to improve treatment outcomes in cancer care.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients with esophageal cancer * Patients receiving a radiotherapy dose \> 40 Gy Exclusion Criteria: * Failure to comply with any of the inclusion criteria
Where this trial is running
Groningen
- University Medical Center Groningen — Groningen, Netherlands (RECRUITING)
Study contacts
- Study coordinator: CT Muijs, MD PhD
- Email: c.t.muijs@umcg.nl
- Phone: +31503615179
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Esophageal Cancer, Acute toxicity, Late toxicity, Prediction models